Skip to Main Content

Everyone loves a winner, but who are they? Let us help you figure it out. Each Friday, we will provide a quick rundown of individuals or companies that accomplished something worth noting. But to be fair, we will also point out those who, well, had a rough time. And if you have a nomination, send us a note. We would not want anyone to feel left out, even the losers.


Joe Papa: As he left Perrigo last year amid investor grumbling, Joe Papa faced an unenviable task — trying to resuscitate a beleaguered Valeant Pharmaceuticals, which has nearly collapsed amid accounting problems, high debt levels, and various government probes into business practices, including its relationship with a specialty pharmacy. Lately, he has been preoccupied selling off assets to reduce debt, but he still faces a mountain. But why should he lose sleep at night? He received compensation last year that was valued at $62.7 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!